Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 15, Issue 4 (July 2013) 15, 449–450; 10.1038/aja.2013.63

A tight junction between E-Cadherin and the prostate tumor suppressor SPDEF

Valeria Coppola and Désirée Bonci

Department of Hematology, Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome 00161, Italy

Correspondence: Dr V Coppola, (valeria.coppola@iss.it)

advance online publication, May 27, 2013

Abstract

Mounting evidence is highlighting the role of the ETS factor SPDEF as a prostate tumor suppressor. In a recent paper by Pal et al., SPDEF was found to transcriptionally control the expression of E-Cadherin, an adhesion molecule with a crucial role in preventing metastatic spread.

PDF | PDF |

 
Browse:  2866
 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.